DABRAFENIB - AN OVERVIEW

Ceritinib is a tyrosine kinase inhibitor that selectively and potently inhibits anaplastic lymphoma kinase (ALK). In normal physiology, ALK functions as a critical phase in the event and performance of nervous system tissue. However, chromosomal translocation and fusion give rise to an oncogenic method of ALK that's been implicated in development o